Piper Sandler Reiterates Overweight on Alkermes, Maintains $39 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has reiterated an Overweight rating on Alkermes (NASDAQ:ALKS) and maintained a $39 price target on the stock.
April 01, 2024 | 2:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler analyst David Amsellem reiterated an Overweight rating on Alkermes with a $39 price target.
The reiteration of an Overweight rating and maintenance of a $39 price target by a reputable analyst could positively influence investor sentiment towards ALKS, potentially driving its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100